Impel Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMPL and other ETFs, options, and stocks.

About IMPL

Impel Pharmaceuticals, Inc. operates as a clinical stage biotechnology firm that develops medical devices. It offers intranasal drug treatments for central nervous system (CNS) disorders. 

CEO
Adrian Adams
CEOAdrian Adams
Employees
129
Employees129
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2008
Founded2008
Employees
129
Employees129

IMPL Key Statistics

Market cap
136.38M
Market cap136.38M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
46.87K
Average volume46.87K
High today
$6.10
High today$6.10
Low today
$5.40
Low today$5.40
Open price
$6.10
Open price$6.10
Volume
24.53K
Volume24.53K
52 Week high
$15.24
52 Week high$15.24
52 Week low
$5.29
52 Week low$5.29

IMPL Earnings

-$1.23
-$0.82
-$0.41
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, Pre-Market
ActualExpected Nov 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.